Reversible aggregation of PABPN1 pre-inclusion structures

Nucleus

Volumn 2, Issue 3, 2011, Pages 208-218

  Raz, Vered ^a   Abraham, Tsion ^a   van Zwet, Erik W ^a   Dirks, Roeland W ^a   Tanke, Hans J ^a   van der Maarel, Silvère M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Nuclear structures; PABPN1; Protein aggregation; Protein dynamic; Protein mobility

Indexed keywords

POLYADENYLIC ACID BINDING PROTEIN;

ARTICLE; BINDING AFFINITY; CELL DIVISION; CONTROLLED STUDY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION;

EID: 79960248001     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.2.3.15736     Document Type: Article

References (31)

1. Di Prospero NA, Fischbeck KH. Therapeutics development for triplet repeat expansion diseases. Nat Rev Genet 2005; 6:756-65.
2. Tavanez JP, Bengoechea R, Berciano MT, Lafarga M, Carmo-Fonseca M, Enguita FJ. Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1. PloS One 2009; 4:6418.
3. Uversky VN. Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci 2008; 9:507-40.
4. David DC, Ollikainen N, Trinidad JC, Cary MP, Burlingame AL, Kenyon C. Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol 2010; 8:1000450;DOI: 10.1371/journal.pbio.1000450.
5. Hands S, Wyttenbach A. Neurotoxic protein oligomerisation associated with polyglutamine diseases. Acta Neuropathologica 2010; 120:419-37.
6. Klein AF, Ebihara M, Alexander C, Dicaire MJ, Sasseville AMJ, Langelier Y, et al. PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression. Exp Cell Res 2008; 314:1652-66.
7. Tavanez JP, Calado P, Braga J, Lafarga M, Carmo- Fonseca M. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. Rna-A Publication of the Rna Society 2005; 11:752-62.
8. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998; 18:164-7.
9. Abu-Baker A, Messaed C, Laganiere J, Gaspar C, Brais B, Rouleau GA. Involvement of the ubiquitinproteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum Mol Genet 2003; 12:2609-23.
10. Berciano MT, Villagra NT, Ojeda JL, Navascues J, Gomes A, Lafarga M, et al. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus. Hum Mol Genet 2004; 13:829-38.
11. Villagra NT, Bengoechea R, Vaque JP, Llorca J, Berciano MT, Lafarga M. Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions. Mol Cell Neurosci 2008; 37:622-33.
12. Tartaglia GG, Pechmann S, Dobson CM, Vendruscolo M. Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci 2007; 32:204-6.
13. Sasseville AMJ, Caron AW, Bourget L, Klein AF, Dicaire MJ, Rouleau GA, et al. The dynamism of PABPN1 nuclear inclusions during the cell cycle. Neuro of Dis 2006; 23:621-9.
14. Reits EA, Neefjes JJ. From fixed to FRAP: measuring protein mobility and activity in living cells. Nat Cell Biol 2001; 3:145-7.
15. Sprague BL, McNally JG. FRAP analysis of binding: proper and fitting. Trends Cell Biol 2005; 15:84-91.
16. Verheesen P, de Kluijver A, van Koningsbruggen S, de Brij M, de Haard HJ, van Ommen GJ, et al. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody. Hum Mol Genet 2006; 15:105-11.
17. Morley JF, Brignull HR, Weyers JJ, Morimoto RI. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci USA 2002; 99:10417-22.
18. Rajan RS, Illing ME, Bence NF, Kopito RR. Specificity in intracellular protein aggregation and inclusion body formation. Proc Natl Acad Sci USA 2001; 98:13060-5.
19. Hein B, Willig KI, Hell SW. Stimulated emission depletion (STED) nanoscopy of a fluorescent proteinlabeled organelle inside a living cell. Proc Natl Acad Sci USA 2008; 105:14271-6.
20. Impagliazzo A, Tepper AW, Verrips TC, Ubbink M, van der Maarel SM. Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD. FEBS Lett 2010.
21. Chartier A, Raz V, Sterrenburg E, Verrips CT, van der Maarel SM, Simonelig M. Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo. Hum Mol Genet 2009; 18:1849-59.
22. Brais B. Oculopharyngeal muscular dystrophy: a polyalanine myopathy. Curr Neurol Neurosci Rep 2009; 9:76-82.
23. Nagai Y, Popiel HA. Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis. Curr Pharm Des 2008; 14:3267-79.
24. Sanchez I, Mahlke C, Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 2003; 421:373-9;DOI: 10.1038/nature01301.
25. Legleiter J, Mitchell E, Lotz GP, Sapp E, Ng C, DiFiglia M, et al. Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo. J Biol Chem 2010; 285:14777-90;DOI: 10.1074/jbc.M109.093708.
26. Olshina MA, Angley LM, Ramdzan YM, Tang J, Bailey MF, Hill AF, et al. Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool. J Biol Chem 2010; 285:21807-16;DOI: 10.1074/jbc.M109.084434.
27. Kuhn U, Gundel M, Knoth A, Kerwitz Y, Rüedel S, Wahle E. Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor. J Biol Chem 2009; 284:22803-14.
28. Junghans RP. Dystrophia myotonia: why focus on foci? Eur J Hum Genet 2009; 17:543-53;DOI: 10.1038/ejhg.2008.227.
29. M, Wojciechowska M, Napierala M, Sobczak K, Krzyzosiak WJ. Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucl Acids Res; 39:3852-63
30. Raz V, Carlotti F, Vermolen BJ, van der PE, Sloos WC, Knaan-Shanzer S, et al. Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells. J Cell Sci 2006; 119:4247-56.
31. Soille P. Morphological Image Analysis: Principles and Applications. Springer-Verlag 2010.